Abstract
In Europe, high incidence rates of oesophageal squamous cell carcinoma (SCCE) are observed in western France (Normandy and Brittany) and in north-eastern Italy. Analysis of TP53 mutations in tumours from these regions has shown a high prevalence of mutations at A:T basepairs that may result from DNA damage caused by specific mutagens. However, the spectrum of TP53 mutations in regions of low incidence is unknown. We report here TP53 mutation analysis in 33 SCCE collected in Lyon, an area of low incidence. These tumours were also examined for MDM2 and P63 amplification, and for expression of p16INK4a/CDKN2a, cyclin E, p27Kipland Cox2. TP53 mutations were detected in 36% of the cases (12/33). In contrast with regions of high incidence, the mutation spectrum did not show a high prevalence of mutations at A:T base pairs. P63 was amplified in 5/32 cases tested (15.5%). No amplification of MDM2 was found. Expression studies revealed frequent loss of p16INK4a/CDKN2a(46%) and p27Kipl(25%) expression, and frequent overexpression of Cyclin E (70%) and Cox2 (42%). Overall, these results indicate that in Europe, SCCE from areas of high and low incidence present a similar pattern of molecular alterations but differ by the type of TP53 mutations. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aggarwal, S, Taneja, N, Lin, L, Orringer, MB, Rehemtulla, A & Beer, DG (2000). Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. Neoplasia, 2, 346–356.
Anayama, T, Furihata, M, Ishikawa, T, Ohtsuki, Y & Ogoshi, S (1998). Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer, 79, 439–443.
Audrezet, MP, Robaszkiewicz, M, Mercier, B, Nousbaum, JB, Bail, JP, Hardy, E, Volant, A, Lozac’h, P, Charles, JF & Goueron, H (1993). TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res, 53, 5745–5749.
Barnas, C, Martel-Planche, G, Furukawa, Y, Hollstein, M, Montesano, R & Hainaut, P (1997). Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer, 71, 79–87.
Biernat, W, Kleihues, P, Yonekawa, Y & Ohgaki, H (1997). Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol, 56, 180–185.
Esteve, A, Lehman, T, Jiang, W, Weinstein, IB, Harris, CC, Ruol, A, Peracchia, A, Montesano, R & Hollstein, M (1993). Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog, 8, 306–311.
Fujii, S, Tominaga, O, Nagawa, H, Tsuno, N, Nita, ME, Tsuruo, T & Muto, T (1998). Quantitative analysis of the cyclin expression in human esophageal cancer cell lines. J Exp Clin Cancer Res, 17, 491–496.
Hibi, K, Trink, B, Patturajan, M, Westra, WH, Caballero, OL, Hill, DE, Ratovitski, EA, Jen, J & Sidransky, D (2000). AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA, 97, 5462–5467.
Hollstein, MC, Peri, L, Mandard, AM, Welsh, JA, Montesano, R, Metcalf, RA, Bak, M & Harris, CC (1991). Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res, 51, 4102–4106.
Itami, A, Shimada, Y, Watanabe, G & Imamura, M (1999). Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology, 57, 311–317.
Launoy, G, Faivre, J, Pienkowski, P, Milan, C, Gignoux, M & Pottier, D (1994). Changing pattern of oesophageal cancer incidence in France. Int J Epidemiol, 23, 246–251.
Launoy, G, Milan, CH, Faivre, J, Pienkowski, P, Milan, CI & Gignoux, M (1997). Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer, 75, 1389–1396.
Launoy, G, Milan, C, Faivre, J, Pienkowski, P & Gignoux, M (2000). Tobacco type and risk of squamous cell cancer of the oesophagus in males: a French multicentre case-control study. Int J Epidemiol, 29, 36–42.
Li, M, Lotan, R, Levin, B, Tahara, E, Lippman, SM & Xu, XC (2000). Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev, 9, 545–549.
Mandard, AM, Hainaut, P & Hollstein, M (2000). Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res, 462, 335–342.
Momand, J, Jung, D, Wilczynski, S & Niland, J (1998). The MDM2 gene amplification database. Nucleic Acids Res, 26, 3453–3459.
Muñoz, N & Day, NE (1996). Esophageal Cancer. D Schottenfeld, JF Fraumeni (eds) Cancer Epidemiology and Prevention, (1996). 681–706, Oxford University Press: Oxford, New York
Muto, M, Hitomi, Y, Ohtsu, A, Ebihara, S, Yoshida, S & Esumi, H (2000a). Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut, 47, 256–261.
Muto, M, Hitomi, Y, Ohtsu, A, Shimada, H, Kashiwase, Y, Sasaki, H, Yoshida, S & Esumi, H (2000b). Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer, 88, 342–350.
Ohashi, Y, Sasano, H, Yamaki, H, Shizawa, S, Shineha, R, Akaishi, T, Satomi, S & Nagura, H (1999). Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Anticancer Res, 19, 1843–1848.
Parkin, DM, Whelan, SC, Ferlay, J, Raymond, L & Young, J (1997). Cancer Incidence in Five Continents, VII, IARC Scientific Publications 143, IARC: Lyon
Parsa, R, Yang, A, McKeon, F & Green, H (1999). Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol, 113, 1099–1105.
Pisani, P, Parkin, DM, Bray, F & Ferlay, J (1999). Estimates of the worldwide mortality from 25 cancers in 1990 [published erratum appears in Int J Cancer 1999 Dec 10; 83(6):870–3]. Int J Cancer, 83, 18–29.
Robert, V, Michel, P, Flaman, JM, Chiron, A, Martin, C, Charbonnier, F, Paillot, B & Frebourg, T (2000). High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis, 21, 563–565.
Shamma, A, Doki, Y, Tsujinaka, T, Shiozaki, H, Inoue, M, Yano, M, Kawanishi, K & Monden, M (2000). Loss of p27(KIPI) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology, 58, 152–158.
Shirvani, VN, Ouatu-Lascar, R, Kaur, BS, Omary, MB & Triadafilopoulos, G (2000). Cyclooxygenase 2 expression in Barrett’s esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology, 118, 487–496.
Tanière, P, Martel-Planche, G, Maurici, D, Lombard-Bohas, C, Scoazec, JY, Berger, F & Hainaut, P (2000a). Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol, 158, 33–40.
Taniere, P, Martel-Planche, G, Puttawibul, P, Casson, A, Montesano, R, Chanvitan, A & Hainaut, P (2000b). TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand. Int J Cancer, 88, 223–227.
Tudek, B, Kowalczyk, P & Ciesla, JM (1999). Localization of chloroacetaldehyde-induced DNA damage in human p53 gene by DNA polymerase fingerprint analysis, IARC Sci Publ 150 279–293.
Tuyns, AJ (1987). Cancer risks derived from alcohol. Med Oncol Tumor Pharmacother, 4, 241–244.
Wang, QS, Sabourin, CL, Wang, H & Stoner, GD (1996). Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis, 17, 1583–1588.
Yamaguchi, K, Wu, L, Caballero, OL, Hibi, K, Trink, B, Resto, V, Cairns, P, Okami, K, Koch, WM, Sidransky, D & Jen, J (2000). Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer, 86, 684–689.
Yang, A, Kaghad, M, Wang, Y, Gillett, E, Fleming, MD, Dotsch, V, Andrews, NC, Caput, D & McKeon, F (1998). p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol Cell, 2, 305–316.
Yang, A, Schweitzer, R, Sun, D, Kaghad, M, Walker, N, Bronson, RT, Tabin, C, Sharpe, A, Caput, D, Crum, C & McKeon, F (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714–718.
Zambon, P, Talamini, R, La Vecchia, C, Dal Maso, L, Negri, E, Tognazzo, S, Simonato, L & Franceschi, S (2000). Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. Int J Cancer, 86, 144–149.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tanière, P., Martel-Planche, G., Saurin, J. et al. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 85, 721–726 (2001). https://doi.org/10.1054/bjoc.2001.1990
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1990